Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature-Reference-Cited by-同舟云学术

Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature

Published:2022-03 Issue:3 Volume:31 Page:
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:European J Cancer Care

Author:

Wang Du¹²^ORCID,Wu Jing³,Du Jianshu⁴,Ong Haley¹,Tang Biwei⁵,Dozier Marshall⁶,Weller David¹,Campbell Christine¹

Affiliation:

1. Usher Institute, Teviot Place University of Edinburgh Edinburgh UK

2. The George Institute for Global Health Peking University Health Science Center Beijing China

3. National Center for Chronic and Non‐communicable Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing China

4. Ordos Central Hospital Ordos China

5. Shenzhen Nanshan Center for Chronic Disease Control Shenzhen China

6. College Lead for Library Academic Support, Medicine & Veterinary Medicine Library & University University of Edinburgh Edinburgh UK

Publisher

Hindawi Limited

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13566

Reference98 articles.

1. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

2. Bruni L. A. G. Serrano B. Mena M. Gómez D. Muñoz J. Bosch F. X. &deSanjosé S.(2018). Human papillomavirus and related diseases in China. Retrieved fromhttps://hpvcentre.net/statistics/reports/XWX.pdf

3. Bruni L. A. G. Serrano B. Mena M. Gómez D. Muñoz J. Bosch F. X. &deSanjosé S.(2019). Human papillomavirus and related diseases in the world. Retrieved fromhttps://hpvcentre.net/statistics/reports/XWX.pdf

4. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

5. Cao K.(2020). The first domestic HPV vaccine has been produced. Retrieved fromhttp://society.people.com.cn/n1/2020/0103/c1008-31534395.html?scene=2&clicktime=1578120587&enterid=1578120587&from=timeline&isappinstalled=0

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inequities in human papillomavirus vaccination among children aged 9–14 years old under constrained vaccine supply in China;International Journal for Equity in Health;2024-05-31

2. Between now and later: a mixed methods study of HPV vaccination delay among Chinese caregivers in urban Chengdu, China;BMC Public Health;2024-01-15

3. The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review;Infectious Diseases of Poverty;2023-12-08

4. Lower rate of mpox vaccination hesitancy and medical consultation among Chinese men who have sex with men living with HIV in comparison with those living without HIV: A national observational study;Human Vaccines & Immunotherapeutics;2023-12-06

5. HPV Infection Profiles among People Living with HIV and HPV Vaccine Acceptance among Individuals with Different HIV Infection Statuses in China: A Systematic Meta-Analysis;Vaccines;2023-10-19